President Gotabaya has no influence in approval of Sinopharm: WHO

The World Health Organisation (WHO) has said, Sri Lankan President Gotabaya Rajapaksa has no influence in the decision by the global body to approve the emergency use of the Sinopharm vaccine.

Sri Lanka had taken the credit for the Chinese Sinopharm vaccine being approved by the WHO.

President’s Spokesman Kingsly Rathnayaka had said that the WHO had approved the vaccine as a result of a discussion President Gotabaya Rajapaksa had with the Director-General of the World Health Organization (WHO) Dr.Tedros Adhanom Ghebreyesus.

In response to a question raised by Daily Mirror, the WHO said that the Emergency Use Listing (EUL) of the WHO process usually takes two to three months to complete, depending on the quality and availability of the data submitted by the vaccine developers, among other factors and the prequalification process is more complex and thus takes longer.

WHO said that in line with their national regulations and legislation, countries have the autonomy to issue emergency use authorizations for any health product.

“Domestic emergency use authorizations are issued at the discretion of countries and not subject to WHO approval,” the WHO said in an emailed response to Daily Mirror.

The WHO added that in emergencies, such as the current COVID pandemic, and for countries whose regulatory authorities are under-resourced, WHO supports the regulatory process by running independent parallel reviews, usually involving independent experts and experts from regulatory authorities at the global level.

Leave a Reply